P

Inventor

VAN ORDEN LORI JEAN

US22 patents
⚠️ This page may combine multiple inventors who share the name “VAN ORDEN LORI JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

16 patents
US10196393B2Feb 5, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US10100049B2Oct 16, 2018

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US11254669B2Feb 22, 2022

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US11453668B2Sep 27, 2022

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11878977B2Jan 23, 2024

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US9669027B2Jun 6, 2017

Hepatitis C virus inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations50
US9260414B2Feb 16, 2016

Inhibitors of hepatitic C virus

THERAVANCE BIOPHARMA R&D IP LLC0 citations50

STANGELAND ERIC L

2 patents

LONG DANIEL D

2 patents

MCKINNELL ROBERT MURRAY

1 patent

NEUMORA THERAPEUTICS INC

1 patent